PMA supplement
P850020 S012: PROSORBA TREATMENT COLUMN FOR RA AND ITP
FDA PMA supplement · Normal 180 Day Track · Fresenius Hemocare, Inc.
Key facts
| Original PMA | P850020 |
|---|---|
| Supplement number | S012 |
| Supplement type | Normal 180 Day Track |
| Reason for the supplement | Postapproval Study Protocol |
| Trade name | PROSORBA TREATMENT COLUMN FOR RA AND ITP |
| Generic name | Separator, automated, blood cell and plasma, therapeutic |
| Applicant | Fresenius Hemocare, Inc. |
| Product code | LKN |
| Received date | Jun 21, 1999 |
| Decision date | Dec 17, 1999 |
At a glance
- No Expedited review granted
- No Approval order on file
- No Summary of safety and effectiveness on file
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMA supplements
A PMA supplement asks FDA to approve a change to a device that already holds a premarket approval: a new indication, a design or labeling change, a manufacturing site or process change.
Source: U.S. Food and Drug Administration (FDA), Premarket Approval (PMA) database · Source date: